U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Showing 1 - 10 of 474 results

Status:
US Approved Rx (2017)
First approved in 2010

Class (Stereo):
CHEMICAL (ABSOLUTE)



Dienogest (Natazia) is a hybrid progestogen that combines properties of both the 19-nortestosterone derivatives and the progesterone derivatives. It is indicated for use by women to prevent pregnancy and for the treatment of heavy menstrual bleeding ...
Status:
US Approved Rx (2018)
First approved in 2010

Class (Stereo):
CHEMICAL (ACHIRAL)



Dalfampridine is a potassium channel blocker, used as a research tool in characterizing subtypes of the potassium channel. Dalfampridine has also been used as a drug, to manage some of the symptoms of multiple sclerosis, and is indicated for symptoma...
Status:
US Approved Rx (2013)
First approved in 2010

Class (Stereo):
CHEMICAL (ACHIRAL)



Polidocanol is a non-ionic surfactant sclerosing agent indicated to treat uncomplicated spider veins and uncomplicated reticular veins in the lower extremity. Polidocanol also is indicated for the treatment of incompetent great saphenous veins, acces...
Status:
US Approved Rx (2010)
First approved in 2010

Class (Stereo):
CHEMICAL (ABSOLUTE)


Conditions:

Ulipristal acetate (also known as CDB-2914 and PGL4001 and trade name Ella in the U.S) is a novel oral emergency contraceptive designed and developed by HRA Pharma. It is a selective progesterone receptor modulator, which reversibly blocks the proges...
Status:
US Approved Rx (2010)
First approved in 2010

Class (Stereo):
CHEMICAL (ABSOLUTE)



Cabazitaxel (JEVTANA®) is an antineoplastic agent belonging to the taxane class and is used to treat people with prostate cancer that has progressed despite treatment with docetaxel. It is prepared by semi-synthesis with a precursor extracted from ye...
Status:
US Approved Rx (2024)
First approved in 2010

Class (Stereo):
CHEMICAL (ABSOLUTE)


Conditions:

ERIBULIN MESYLATE (HALAVEN®) is a microtubule dynamics inhibitor. It is a synthetic analog of halichondrin B, a product isolated from the marine sponge Halichondria okadai. ERIBULIN MESYLATE (HALAVEN®) inhibits the growth phase of microtubules withou...
Status:
US Approved Rx (2010)
First approved in 2010

Class (Stereo):
CHEMICAL (ACHIRAL)



Alcaftadine is a broad-spectrum antihistamine displaying a high affinity for histamine H1 and H2 receptors and a lower affinity for H4 receptors. It also exhibits modulatory action on immune cell recruitment and mast cell stabilizing effects. Alcafta...
Status:
US Approved Rx (2021)
First approved in 2010

Class (Stereo):
CHEMICAL (ABSOLUTE)



Carglumic acid is a Carbamoyl Phosphate Synthetase 1 (CPS 1) allosteric modulator. CPS1 is found in the mitochondria and is the first enzyme of the urea cycle, which converts ammonia into urea. Carglumic acid acts as a replacement for NAG in NAGS def...
Status:
US Approved Rx (2010)
First approved in 2010

Class (Stereo):
CHEMICAL (ABSOLUTE)



Ceftaroline is a fifth-generation broad-spectrum cephalosporin with potent antimicrobial activity against Gram-positive and Gram-negative pathogens. Ceftaroline is the bioactive metabolite of ceftaroline fosamil, an N-phosphonoamino water-soluble cep...
Status:
US Approved Rx (2021)
First approved in 2010

Class (Stereo):
CHEMICAL (ACHIRAL)



Dabigatran (Pradaxa, Prazaxa) is an anticoagulant medication that can be taken by mouth. FDA approved on October 19, 2010. Dabigatran directly inhibits thrombin in a concentration-dependent, reversible, specific, and competitive manner which results ...